FDA 510(k)
FDA class 1
Substantially Equivalent
🇺🇸 United States
PROSTATE-63 CANCER DIAGNOSTIC TEST
K Number: K050063
·
Decision Feb 9, 2005
Classifications
1
FEI Numbers
1
Registration Numbers
1
Same Product Code
0
Applicant Total
1
Review Days
29
Basic Information
- Device Name
- PROSTATE-63 CANCER DIAGNOSTIC TEST
- K Number
- K050063
- Device Class
- FDA class 1
- Clearance Type
- Traditional
- Regulation Number
- 864.1860
- Medical Specialty
- Hematology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- ASYMMETRX
- Date Received
- January 11, 2005
- Decision Date
- February 9, 2005
- Product Code
- NTR
- Advisory Committee
- Hematology
- Review Advisory Committee
- PA
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| NTR | Immunohistochemical Reagent, Antibody (Monoclonal Or Polyclonal) To P63 Protein In Nucleus Of Prostatic Basal Cells | FDA class 1 | Hematology |